FreshRecalls

FDAClass II · Medical device · Recalled June 24, 2026

iLet Bionic Pancreas recall — Beta Bionics, Inc.

Hazard: The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.

Class II: may cause temporary or medically reversible health consequences.

Official recall ID
Z-2513-2026
Brand
Beta Bionics
Classification
Class II
Units affected
4,580
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

iLet Bionic Pancreas, REF: BB1001

Affected products

Companies & origin

Recalling firm location
Irvine, CA, United States
Firm address
11 Hughes, 92618-1902

Identifying details (verbatim from the notice)

Product codes / lots
iLet ACE Pump firmware BOM000072 Rev C (version 3.3.6) and BOM000072 Rev B (version 3.3.4)
Distribution
US: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC, CT, MN, VA, OK, AR, AZ, MO, MT, RI, DC, NM, OR, ID, NV, AK, ND, DE, WV, WY, SD, UT, AL
Firm notified the public via
Letter
FDA event ID
98517
Recall initiated
September 23, 2025
FDA classified
June 18, 2026
FDA report date
June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page